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SYSTEMS AND METHODS FOR COGNITIVE DIAGNOSTICS FOR





The present disclosure relates generally to the field of cognitive diagnostics. More
particularly, the present disclosure relates to systems and methods for cognitive diagnostics
in connection with Parkinson’s disease, comorbid major depressive disorder and response to
antidepressants.
RELATED ART
Parkinson’s Disease (PD) is a neurological disease that affects specific brain cells
and produces symptoms that include muscle rigidity, tremors, and changes in speech and
gait. Mental health is extremely important in PD. Although common in other chronic
diseases, research suggests that depression and anxiety are even more common in PD. It is
estimated that at least 50 percent of those diagnosed with PD will experience some form of
comorbid major depressive disorder (“MDD”) during their illness, and up to 40 percent will
experience anxiety disorders. Most current solutions for early or initial diagnosis of
Parkinson’s and comorbid MDD are performed using rating scales or questionnaires with
tests performed by healthcare providers when patients report specific symptoms.
MDD is characterized by a long-lasting depressed mood or marked loss of interest
or pleasure in all or nearly all activities. Antidepressants, including serotonin-specific
reuptake inhibitors (hereinafter “SSRI”), can remediate depressive symptoms in a substantial
proportion of patients suffering from MDD. It has been hypothesized that SSRIs achieve
their therapeutic effect, in part, by modifying synaptic availability of serotonin and possibly
also by enhancing neurogenesis in the hippocampal region. Yet, little is known about the
underlying brain structure and neurochemistry in MDD. As a result, MDD diagnosis is based
primarily on overt behavioral symptoms. Moreover, such diagnoses are given in a long
interview with a medical professional and/or based on a form that is filled out by a patient
or caretaker. Despite being accurate, such procedures for diagnosing MDD can take a long
time to complete and require regular visits to professionals. Moreover, most patients with
MDD do not respond positively to antidepressants and the current procedures for diagnosing
MDD do not predict whether a patient will respond to antidepressants at all.
PD and MDD are discussed in the paper entitled “Depression Reduces Accuracy
While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients
with Parkinson’s Disease with Comorbid Major Depressive Disorder Tested on a
Probabilistic Category -Learning Task,” by Herzallah, et al, Frontiers in Psychiatry, June
2017, Vol. 8, Art. 84.
SUMMARY
The present disclosure provides a computer system and method which can collect
data from a participant. The participant can interact with a computer device (e.g., a tablet or
smartphone) through a short (e.g., ~10 minutes) feedback-based probabilistic classification
cognitive task (hereinafter “FPCT”) during which data can be collected. The data can be
processed by the computer device or a remote device in communication with the computer
device over a network. The processing of the data can determine attributes of a patient in
connection with the dissociation of learning from positive versus negative feedback or other
forms of feedback-based learning (e.g., correct feedback versus incorrect feedback or
reinforcement learning). The computer device can make this determination based on
mathematical models and artificial intelligence approaches to extract additional measures.
Based on the output of the computer device, a diagnosis of Parkinson’s disease can be made.
In addition, the results thereby generated can be used to assess whether the patient also has
a comorbid major depressive disorder.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing features of the invention will be apparent from the following Detailed
Description, taken in connection with the accompanying drawings, in which:
FIG. 1 is a drawing illustrating an embodiment of a flow diagram of a system of the
present disclosure;
FIGS. 2A-B are drawings showing graphs of a result from testing a first example
cognitive task of the system of the present disclosure;
FIGS. 3A-B are drawings showing graphs of a result from testing a second example
cognitive task of the system of the present disclosure;
FIGS. 4A-D are drawings showing sample screens of a feedback-based classification
task in the system of the present disclosure;
FIGS. 5A-H are drawings showing graphs of testing results of the system of the
present disclosure;
FIGS. 6A-B are drawings showing two classification graphs for tests conducted in
connection with the system of the present disclosure;
FIGS. 7A-C are drawings showing graphs of results of another test performed on the
system of the present disclosure;
FIG. 8 is a graph illustrating mean positive and negative bias before and after
treatment in connection with a test of the system of the present disclosure;
FIG. 9 is a diagram illustrating hardware and software components of the system of
the present disclosure;
FIG. 10 is a diagram illustrating hardware and software components of a computer
system on which the system of the present disclosure could be implemented;
FIG. 11 is a drawing illustrating another aspect of a flow diagram of a system of the
present disclosure;
FIG. 12 is a schematic illustration of the system and method of the present disclosure
for use in connection with Parkinson’s disease;
FIG. 13 is a drawing showing a classification graph for tests conducted in connection
with the system of the present disclosure; and
FIG. 14 is a drawing showing a classification graph for tests conducted in connection
with the system of the present disclosure.
DETAILED DESCRIPTION
The present disclosure relates to systems and methods for cognitive diagnostics in
connection with major depressive disorder and response to antidepressants, as discussed in
detail below in connection with FIGS. 1-14.
The present disclosure uses Major Depressive Disorder (“MDD”) as an example of
a psychiatric disorder, however, the system of the present disclosure can be used to diagnose
any psychiatric disorder, including, but not limited to, post-traumatic stress disorder,
obsessive compulsive disorder, schizophrenia, and other anxiety spectrum disorders.
Moreover, the present disclosure refers to antidepressants and/or serotonin-specific reuptake
inhibitors (hereinafter “SSRI”) as examples of treatment, however, the system of the present
disclosure can be used to predict whether a patient will respond to any number of other
treatment modalities such as psychotherapy and others.
The present disclosure provides a computer system and method which can collect
data from one or more patients. These patients can interact with a computer device (e.g., a
tablet or smartphone) through a short (e.g., ~10 minutes) feedback-based probabilistic
classification cognitive task (hereinafter “FPCT”) during which data can be collected. The
data can be processed by the computer device or a remote device in communication with the
computer device over a network. The computer device can be a local device for a closed-
circuit system. The processing of the data can determine attributes of a patient in connection
with the dissociation of learning from positive versus negative feedback. The computer
device can make this determination based on mathematical models and artificial intelligence
approaches to extract additional measures. Based on the output of the computer device, a
diagnosis of major depressive disorder (hereinafter “MDD”) can be made. In addition, the
results thereby generated can be used to predict whether the patient will respond to
antidepressants.
FIG. 1 is a drawing illustrating an embodiment of a flow diagram 2 of the present
disclosure. The flow diagram 2 includes cognitive and computational and artificial
intelligence markers having a FPCT step 4, variants of the Q-learning reinforcement learning
model (RLM) 6, and variants of the drift-diffusion model (DDM) 8 . The FPCT step 4 can
be for collecting information relating to the results of the FPCT task a patient performed.
The FPCT step 4 can include an accuracy component 10, an accuracy processing bias
component 12, and a response time component 14. The accuracy component 10 can include
factors relating to positive and negative feedback as will be explained in greater detail below.
The response time component 14 can also include factors relating to positive and negative
feedback as will be discussed in greater detail below.
The FPCT step 4 can output its collected cognitive data such as the accuracy
component 10 and the response time component 14 for processing by various computational
models and artificial intelligence approaches. In particular, the accuracy component 10 can
output its data for processing by the RLM models 8 which can be used to assess parameters
related to learning accuracy. Moreover, the response time component 14 can output its data
for processing by the DDM models 6 which can be used for assessing parameters related to
response time distributions. Cognitive data from the FPCT step 4 and outputs from the DDM
computational models 6 and the RLM computational models 8 can be sent to a binomial or
multinomial logistic regression model 16 which can accurately determine MDD patients
from healthy subjects. Further, the binomial or multinomial logistic regression model 16
can use the same data to accurately determine responders and non-responders to
antidepressants. The multinomial logistic regression model 16 can include one or more
classification algorithms and artificial intelligence approaches to make these determinations.
For example, with respect to diagnosing a patient with MDD, cognitive predictors can
include, but are not limited to, learning accuracy from positive feedback, response time to
positive feedback, learning accuracy from negative feedback, and response time to negative
feedback. With respect to diagnosing a patient with MDD, computational predictors can
include, but are not limited to, positive learning rate, negative learning rate, separation
threshold, difference in the speed of response for the execution of responses, and drift rate
for negative feedback. With respect to determining whether a patient will respond to
treatment, cognitive parameters include, but are not limited to, learning accuracy from
negative feedback, accuracy processing bias, response time to negative feedback, and
response time to positive feedback. With respect to determining whether a patient will
respond to treatment, computational parameters include, but are not limited to, preservation,
valuation of positive feedback, valuation of negative feedback, separation threshold, and
starting point of evidence for decision making.
Examples of cognitive tasks will now be explained in greater detail. This learning
task requires participants to leam a sequence of events leading to reward. One example of
a cognitive task can be sequence learning and context generalization. It should be noted that
the sequence learning and context generalization and chaining tasks are merely examples of
a type of task that can be used. The present disclosure is not limited to the exact
methodologies of the sequence learning and context generalization tasks described herein.
Other variations of the tasks can be used, and the following sequence learning and context
generalization task is for illustrative purposes. In the first phase of the task, a computer
device can generate a screen which shows a first room (Room 1) with three doors (Al, A2,
A3), each identified by its own color. The computer device can allow a participant to choose
one of the doors. The computer device can set the correct response as door Al, which can
lead to a reward, such as a treasure chest. The incorrect responses can be set as doors A2 or
A3, which can lead to a locked door. If the participant selects an incorrect door, the subjects
can be prompted to try again. Once the participant learns that door Al is associated with a
reward, the computer device can present the participant with another room (Room 2). This
room can have three new colored doors (Bl, B2, B3). The computer device can set the
incorrect responses to doors B2 and B3 which can lead to a locked door. The computer
device can also set the correct response to door Bl which can lead to Room 1, in which the
participant would again be presented with the doors Al, A2, and A3 where the same door as
previously presented would lead to the reward and the other doors would lead to locked
doors. This will allow the participant to leam an association where selecting Bl and then
Al leads to a reward. Once this new association is learned, a new room (Room 3) can be
added to the sequence where doors Cl, C2, and C3 are presented to a participant. C2 and
C3 can be set to lead to a locked door while Cl can lead to Room 2 as discussed above. Now
the participant will leam an association where selecting Cl, Bl, and Al leads to a reward.
Once this association is learned, the participant can be presented with Room 4 with doors
Dl, D2, and D3. D2 and D3 can be set as incorrect responses and D 1 (the correct response)
can lead to Room 3 . Here, the participant can leam an association that selecting Dl, Cl, Bl,
and Al leads to a reward. It should be noted that the above process is not limited to a three-
door situation with a specific number door having the reward. The above cognitive task is
merely an example task that can be used in the system of the present disclosure.
Nevertheless, the system of the present disclosure can include other cognitive tasks for
chaining and sequence mechanisms with context generalization. The above process can be
seen in Table 1 below.
Table 1
In the context generalization phase as shown above in Table 1, generalization to
novel task demands can be tested by presenting various novel incorrect doors as distractors
along with a correct door choice in each room. This can require participants to learn the
correct response and context associations to obtain the reward as shown in Table 1.
FIGS. 2A-B are graphs which show an example result of testing the above cognitive
task. As can be seen, FIG. 2A shows performance on the sequence learning and context
generalization task such as the mean number of errors on the sequence-learning phase of the
task (chain steps A-D as shown in Table 1). FIG. 2B also shows the mean numbers of errors
on the context generalization phase. In the graphs of FIGS. 2A-B, MDD represents
medication naive patients, MDD-T represents patients on medication, and HC represents
healthy control subjects. The results show that persons with MDD that are not being treated
with medication tend to make many errors on the initial learning/chaining phase, but persons
with MDD on medication treatment make many errors in the contextual generalization
phase. Univariate ANOVA (alpha=0.05) indicated a significant group difference in the
chaining phase results [F(2,24)=4.25, p=0.026, partial n2=0.261] as well as the context
generalization phase results [F(2,24)=16.90, pO.OOl, partial n2=0.59]. In the sequence-
learning phase results, an HSD post hoc test revealed a significant difference between MDD
and HCs and between MDD and MDD-T (p<0.05), but not between HCs and MDD-T. In
the context generalization phase, an HSD post hoc test revealed a significant difference
between MDD-T and HCs, and between MDD-T and MDD (pO.OOl), but not between HCs
and MDD. An a priori power analysis of one-way ANOVA, done to compute the number
of subjects required per group to get a power of 95%, showed that a sample of 48 subjects
( 16 per group) can be needed to achieve the mentioned power level on the chaining ANOVA,
and a total sample of 15 subjects (5 per group) to achieve 95% power level on the context
generalization ANOVA.
A second example cognitive task will now be explained in greater detail. The second
cognitive task can use a reward-and-punishment-based computer-learning task for weather
prediction. In each phase of the task, a computer device can generate four stimuli such as
abstract geometric paintings. A participant can view a painting and the device can ask the
participant whether that painting predicts rainy weather or sunny weather. The computer
device can be programmed so that choosing an answer with respect to two of the stimuli
(e.g., paintings) provide feedback for correct answers and incorrect answers result in no
feedback. The computer device can also be programmed so that choosing an answer in
connection with the other two stimuli provide feedback for incorrect answers and no
feedback is given for correct answers. Among both the reward-trained and punishment-
trained cues, equal numbers can be associated with rainy weather and sunny weather. All
four cues can be intermixed during training. This task is not limited to any specific
methodology and can include other tasks related to reward-and-punishment mechanisms.
The cognitive tasks described in the present disclosure can also have the ability to
change based on user input providing a dynamic functionality. In particular, the cognitive
tasks can change a stimulus or task or question based on a user’s prior response(s). For
example, if a user is answering questions correctly, the system can increase the difficulty of
a subsequent question. Moreover, if a user is answering questions incorrectly, the system
can decrease the difficulty of a subsequent question. In this way, the cognitive tasks of the
present disclosure are tailored to a user’s abilities. Furthermore, the system can change a
task to a different task based on the user’s input. The system can take into account a plurality
of different trials and present a tailored subsequent trial to a user. Accordingly, the systems
and methods of the present disclosure can function as a closed loop system for diagnosing
mental health conditions and responsiveness to treatments.
FIGS. 3A-B are graphs which show an example result of testing the above cognitive
task. The results tested 13 medication-naive MDD, 18 MDD-T (Treated, on medication),
and 22 healthy controls (HC). FIGS. 3A-B show performance on the two types of trials of
the reward and punishment learning task. For example, the mean number of correct
responses in the four phases for the reward stimuli is shown in FIG. 3A and the mean number
of correct responses in the four phases for the punishment stimuli is shown in FIG. 3B. As
noted above, MDD represents patients who are medication naive and MDD-T represents
patients on medication. As can be seen in FIG. 3A, the results show no difference in
performance on reward training between MDD and MDD-T being impaired in that phase
using one-sample t-test to assess learning higher than chance. In a one-way ANOVA
(Bonferroni correction of a=0.025 to protect the level of significance), using the 4th block
of reward and punishment trials as the dependent variable, there existed a significant effect
of group on learning from punishment [F(2,27)=4.821, p=0.016, n2=0.249] but not on
learning from reward [F(2,27)=0.49, p=0.618] A post hoc analysis of the group effect on
4 lll-block punishment learning revealed a significant difference between MDD-T patients
and MDD patients, and between MDD-T patients and HC (p<0.05). A priori power analysis
for ANOVA revealed that the test can have a total of 5 1 subjects (17 per group) to obtain a
power of 95%.
As noted above, the system of the present disclosure can collect data of the
participants progress in the above example cognitive tasks and variations thereof. The
system of the present disclosure can process this data using a binomial or multinomial
logistic regression algorithm to classify subjects as either having MDD or not, and if they
do have MDD, whether the subjects would respond to certain medications such as
antidepressants. Other classification approaches can be used such as random forest, auto
encoders, or other artificial intelligence and machine learning approaches. Random forest
or auto-encoders can offer, in some circumstances, better and quicker results, and can utilize
a greater number of predictors. Furthermore, the system of the present disclosure can use
the Softmax function in making its classification determinations. It should be noted that the
above tasks can be performed in a relatively short period of time (e.g., 15 minutes).
The system of the present disclosure can collect data relating to the time it takes for
a participant to respond to the scenarios discussed herein. Depending on the time it takes
for the participant to respond, the classification algorithm of the system of the present
disclosure can take this information as an input and make determinations regarding MDD
and ability to respond to treatments for MDD. As noted above, the data gathered during the
cognitive tasks and used by the classification algorithms and artificial intelligence
approaches can include, but is not limited to, accuracy of correct answers, incorrect answers,
response time, response time as the task progresses, learning progress, and how much the
participants value positive and negative feedback. These data points can be processed by
the classification algorithm and artificial intelligence approaches to make a determination as
to whether a patient has a particular psychiatric disorder and whether that patient will
respond to treatment.
The system of the present disclosure can vary the amount of positive/negative
feedback associated with stimuli. With learning accuracy in positive and negative feedback
being one of the key cognitive predictors, and valuation of feedback being one of the key
computational predictors, the system can add new stimuli to the current FPCT with various
amounts of positive and negative feedback to get clearer results related to feedback
processing.
The system of the present disclosure can also use conflict trials while diagnosing
MDD and responsiveness to medications. For example, in some cases, there can be a
feedback processing bias that can differentiate clinically depressed vs. non-depressed
subjects as well as responders and non-responders. The subject can leam the feedback
associated with each stimulus, and it can be expected that subjects develop preferences to
stimuli associated with particular feedback. Accordingly, conflict trials can be used to
account for these factors.
The system of the present disclosure can also add multiple phases with more stimuli.
In particular, the MDD state and potential response to treatment can be expressed cognitively
as preferential learning of particular stimuli with particular feedback. Therefore, adding
more stimuli while escalating the level of complexity of the FPCT can refine the underlying
factors for preferential learning which improves the efficiency of the classification model.
The system of the present disclosure can add galvanic skin response (GSR) or an
eye-tracker to assess eye movements as well as pupil size as additional predictors. By adding
GSR, eye-tracking, or electroencephalography (EEG), the system can present an unbiased
physiological measure to accompany the cognitive measures from the FPCT. Sensors and
electrodes can be placed on a patient’s body, their eyes, and/or their scalp which can gather
physiological data which can be communicated to a computer device in the system of the
present disclosure. This computer device can process the data from the sensor to determine
the emotions (e.g., happiness, fear, etc.) felt by the patient while completing the tasks
described herein. Data from the eye-tracker can also be analyzed to specify the points of
focus as well as changes in pupil size. Data from EEG can track changes in brain electrical
activity during the FPCT or at baseline (before/after cognitive testing). The classification
algorithm can receive these data as input and can use such information in providing enhanced
classifications as to a diagnosis and whether a patient will respond to treatment and the best
treatment to offer.
The system of the present disclosure can also apply the above processes and cognitive
tasks to diagnose other psychiatric disorders including, but not limited to, post-traumatic
stress disorder, obsessive compulsive disorder, schizophrenia, and other anxiety spectrum
disorders.
The system of the present disclosure can also test patients after they have received
antidepressants to determine whether they responded to the treatment or whether they are
still depressed. This can be done by leveraging the cognitive tasks discussed above.
The system can also predict a patient’s response to psychotherapy in addition to
antidepressants. The classification algorithm and artificial intelligence approaches as
discussed above can use the data captured from the tasks and make a determination as to
whether a patient will respond to psychotherapy. The system can also determine whether
antidepressants or psychotherapy will be better for a given patient based on the cognitive
tasks discussed above.
A test with respect to the system of the present disclosure will now be described in
greater detail. This test includes 67 medication-naive patients with MDD and 16 matched
healthy controls from various clinics in the Palestine area. A positive and negative feedback
classification task for weather prediction was used given by Table 2 below:
Table 2
FIGS. 4A-B are drawings showing sample screens of a feedback-based classification
task. These are the screens that were used in the above trial. On each trial, a participant saw
one of four stimuli and was asked whether this stimulus predicts rainy or sunny weather. In
screen 4B, no feedback is given for incorrect answers in positive feedback stimuli or correct
answers in negative feedback stimuli. As shown in screen 4C, for positive feedback stimuli,
correct responses receive positive feedback with visual feedback and twenty five points of
winnings. As shown in screen 4D, for negative feedback, incorrect responses get negative
feedback with visual feedback and the loss of 25 points. In the FCPT task, the subject sees
one of four stimuli (abstract geometric paintings) and is asked to make a prediction. For
example, the subject is asked whether that stimulus predicts Rain or Sun. Two of the stimuli
are trained using only positive feedback for correct answers (incorrect answers result in no
feedback). The other two stimuli are trained using only negative feedback for incorrect
answers (correct answers result in no feedback). Among both the positive-feedback-trained
and negative-feedback-trained cues, one is more strongly associated with Rain and the other
with Sun. These associations are probabilistic, so that, for example, a rain-preferred cue is
associated with 90% Rain and 10% Sun.
The above test used a variant of the Q-leaming trial-by-trial computational analysis
to calculate estimates for the following parameters: learning rate with positive prediction
error (LR+); learning rate from negative prediction error (LR-); preservation; noise (beta);
and valuation of feedback (R0+, R0-). It also used a variant of the DDM trial-by-trial
computational analysis to calculate estimates for the following parameters: drift rate (v) for
positive-feedback and negative-feedback; threshold separation (a); relative starting point
(zr); non-decision time (tO); and difference in decision time for correct and incorrect
responses (d). The results of the above test can be seen in FIGS. 5A-H. As can be seen in
FIGS. 5A and 5B, cognitive and computational analysis results show learning accuracy in
positive and negative feedback trials. FIGS. 5C and 5D show response time to positive and
negative feedback stimuli. FIGS. 5E and 5F show positive/negative accuracy bias. FIG. 5G
shows parameter estimates using a 6-parameter Q-leaming model. FIG. 5H shows parameter
estimates using a 6-parameter DDM analysis.
FIGS. 6A-B are drawings showing classification graphs for the above test conducted
in connection with the system of the present disclosure. As can be seen, a forward binomial
logistic regression classification graph shows a predicted probability of membership for
MDD SSRI responder vs. non-responder in FIG. 6A and MDD vs. healthy in FIG. 6B. The
cutoff value can be 0.50. In FIG. 6A, R denotes a responder and N denotes a non-responder.
In FIG. 6B, M denotes MDD and H denotes healthy subject. Each symbol represents two
and a half cases. Four symbols on the graph represent one case.
The above test shows learning accuracy and response time to positive feedback and
learning accuracy and response time to negative feedback can differentiate potential patients
with MDD from healthy subjects. It also shows learning accuracy and response time to
negative feedback can a priori differentiate potential SSRI-responders and non-responders
at the medication-naive level. These results provide an easy to use diagnostic tool that can
have immediate clinical relevance. Moreover, it shows lower positive learning rate and
learning noise in patients with MDD than healthy subjects. SSRI non-responders exhibit
higher levels of preservation during learning. Further, SSRI non-responders value n o
feedback in negative feedback trials as negative, which can explain the deficit in negative
feedback learning accuracy. It also shows higher threshold separation (a), higher difference
in decision time for correct and incorrect responses (d), lower non-decision time (stO), and
lower drift rate for negative feedback (v-p). This could explain the slower response time in
patients with MDD. In addition, MDD is associated with a selective deficit in learning from
positive feedback. SSRI non-responders have balanced learning from positive and negative
feedback at the medication-naive state similar to healthy subjects.
Another test with respect to a positive and negative feedback probabilistic
classification task was conducted in connection with the system of the present disclosure. In
particular, 67 medication naive patients with MDD and 16 matched healthy controls
participated in Palestine. Patients with MDD were retested 4-6 weeks after starting
paroxetine regimen. Healthy controls were also retested at a similar time interval. Response
to paroxetine was considered positive if a patient’s Beck Depression Inventory II score
dropped 50 percent from baseline, and the patient screened negative for MDD on the Mini
International Neuropsychiatric Interview. The same positive and negative feedback
probabilistic feedback classification task for weather prediction can be used with a feedback
structure given by Table 2 above. A similar user interface can also be used as shown in
FIGS. 4A-D.
FIGS. 7A-C shows results of the test discussed above. Performance on the positive
and negative feedback learning task is shown. In FIG. 7A, the graph shows that the mean
number of optimal responses in the four phases for the positive feedback stimuli. In FIG.
7B, the graph shows the mean number of optimal responses in the four phases for the
negative feedback stimuli. In FIG. 7C, the graph shows the mean difference between
percentage optimal responses in positive and negative feedback trials per block. MDD.R-
MN represents participants that are medication-naive with MDD and who are SSRI
responders. MDD.R-T represents participants who are SSRI responders. MDD.NR-MN
represents participants who are medication-naive with MDD who are SSRI non-responders.
MDD.NR-T represents participants who are SSRI non-responders. HC test represents
healthy controls at baseline and HC retest are healthy controls after 4-6 weeks.
FIG. 8 is a graph illustrating mean positive and negative bias before and after SSRI
treatment. As can be seen, FIG. 8 shows a mean difference between percentage optimal
responses in positive and negative feedback trials across blocks per testing session before
and after SSRI treatment for MDD and at-test and retest for healthy subjects. MDD-mn
(test) is medication-naive baseline for MDD and baseline for healthy subjects. MDD-t
(retest) is SSRI-treated retesting for MDD patients 4-6 weeks after SSRI administration and
retesting at 4-6 weeks for healthy subjects. The conclusions from this test shows that
learning from negative feedback can differentiate potential SSRI-responders and non
responders at the medication-naive level. Moreover, SSRI-responsive MDD is associated
with a selective deficit in learning from positive feedback. Further, SSRI non-responders
have balanced learning from positive and negative feedback at the medication-naive state.
Finally, SSRI administration suppresses learning from negative feedback in responders only,
thereby bringing positive and negative feedback learning into balance.
FIG. 9 is diagram illustrating hardware and software components of the system of
the present disclosure. A system 100 can include a mental health diagnostics computer
system 102. The mental health diagnostics computer system can include a database 104 and
a mental health diagnostics processing engine 106. The system 100 can also include a
computer system(s) 108 for communicating with the mental health diagnostics computer
system 102 over a network 110. The computer systems 108 can be computer devices in
which the participants perform the tasks as described above. Network communication could
be over the Internet using standard TCP/IP communications protocols (e.g., hypertext
transfer protocol (HTTP), secure HTTP (HTTPS), file transfer protocol (FTP), electronic
data interchange (EDI), etc.), through a private network connection (e.g., wide-area network
(WAN) connection, emails, electronic data interchange (EDI) messages, extensible markup
language (XML) messages, file transfer protocol (FTP) file transfers, etc.), or any other
suitable wired or wireless electronic communications format. The computer system 108
can also be a smartphone, tables, laptop, or other similar device. The computer system 108
could be any suitable computer server (e.g., a server with an INTEL microprocessor,
multiple processors, multiple processing cores) running any suitable operating system (e.g.,
Windows by Microsoft, Linux, etc.). Alternatively, the computer system could be a field-
programmable gate array (FPGA) that can run the mathematical models and artificial
intelligence approaches simultaneously upon receipt of the cognitive data in a closed-loop
system.
FIG. 10 is a diagram illustrating hardware and software components of a computer
system on which the system of the present disclosure could be implemented. The system
100 comprises a processing server 102 which could include a storage device 104, a network
interface 118, a communications bus 110, a central processing unit (CPU) (microprocessor)
112, a random access memory (RAM) 114, and one or more input devices 116, such as a
keyboard, mouse, etc. The server 102 could also include a display (e.g., liquid crystal display
(LCD), cathode ray tube (CRT), etc.). The storage device 104 could comprise any suitable,
computer-readable storage medium such as disk, non-volatile memory (e.g., read-only
memory (ROM), erasable programmable ROM (EPROM), electrically-erasable
programmable ROM (EEPROM), flash memory, field-programmable gate array (FPGA),
etc.). The server 102 could be a networked computer system, a personal computer, a smart
phone, tablet computer etc. It is noted that the server 102 need not be a networked server,
and indeed, could be a stand-alone computer system.
The functionality provided by the present disclosure could be provided by a mental
health diagnostics program/engine 106, which could be embodied as computer-readable
program code stored on the storage device 104 and executed by the CPU 112 using any
suitable, high or low level computing language, such as Python, Java, C, C++, C#, .NET,
MATLAB, etc. The network interface 108 could include an Ethernet network interface
device, a wireless network interface device, or any other suitable device which permits the
server 102 to communicate via the network. The CPU 112 could include any suitable single-
or multiple-core microprocessor of any suitable architecture that is capable of implementing
and running the mental health diagnostics engine 106 (e.g., Intel processor). The random
access memory 114 could include any suitable, high-speed, random access memory typical
of most modem computers, such as dynamic RAM (DRAM), etc.
FIG. 11 is a drawing of a flow diagram 200 of another aspect of the system of the
present disclosure. The flow diagram 200 illustrates a cognitive component 210, a
computational component 220, a classifier component 230 and an output 240. As shown in
FIG. 11, an emphasis on the dynamic interaction between the cognitive component 210 and
the computational component 220 of the system provides for maximizing an accuracy of the
classifier component 230.
The cognitive component 210 includes a plurality of trial blocks 212a, 212b and
212c. Each trial block 212a, 212b, and 212c can include a specified number of trials, a
specified number of trial types and a working memory test. Additionally, trial blocks 212b
and 212c can include additional features including, but not limited to, outcome reversal,
outcome devaluation, gain/loss value modification and delay discounting. These additional
features provide for atrial block following a preceding trial block to explore non-dispositive
results from the preceding trial block. For example, trial block 212b could be designed with
additional features such as gain/loss value modification and delay discounting to explore
non-dispositive results from trial block 212a or other cognitive demands related to
mental/psychiatric disorders.
The computational component 220 can analyze the cognitive results of each trial
block 212a, 212b and 212c utilizing a plurality of modeling and artificial intelligence
approaches on a trial by trial basis in real time. Specifically, upon initiation of a cognitive
task of a trial block 212a-c, the computational component 220 performs the trial-by-trial
computational analysis in real-time while the subject is performing the cognitive task. The
plurality of modeling approaches can include, but are not limited to, prediction error learning
(PEL) 222a-c, gain learning (GL) 224a-c, loss learning (LL) 226a-c and stimulus-by-
stimulus learning (SSL) 228a-c. DDM trial-by-trial analysis of cognitive data can be
conducted in parallel. Each of the plurality of modeling approaches can include a set of
operating parameters. For example, PEL 222a-c can include operating parameters such as
positive learning rate, negative learning rate, and noise, and GL 224a-c can include operating
parameters such as gain learning rate, noise, preservation, and valuation of no-feedback.
Additionally, LL can include operating parameters such as loss learning rate, noise,
preservation, and valuation of no-feedback, and SSL can include operating parameters such
as positive learning rate, negative learning rate, noise, preservation and valuation of n o
feedback.
Conventional computer-based cognitive tasks suffer from static design that typically
does not change throughout an execution of a cognitive task. As such, the system utilizes
the cognitive component 210 to design and generate a dynamic cognitive task wherein the
performance of the subject influences a design of a subsequent trial block, an addition of
various features, and/or the repetition of some of the previously used trial types for further
analysis. By fine-tuning a measurement of the cognitive features and the computational
parameters, the system can maximize the classification abilities of the classifier component
230.
Specifically, the system utilizes dynamic cognitive task-computational model
coupling to maximize the classification abilities of the classifier component 230. For
example, for a trial, the cognitive task can transmit a trial type, accuracy, and response time
to the various computational models 222a-c, 224a-c, 226a-c and 228a-c to extract parameters
of the learning process. Accordingly, over a course of 10-20 trials per trial type, measures
of central tendency (e.g., mean and median) as well as variability (e.g., standard deviation,
skewness, and kurtosis) can be evaluated and compared to parameters extracted from a large
pool of healthy subject data (e.g., a pool of approximately 1000 subjects). Upon ascertaining
a difference or a lack of a difference between parameters of the tested subject, the cognitive
results and the computational parameters can be adjusted. If the cognitive results and the
computational parameters are not adjusted, additional testing of the same type of trials can
be resumed in a subsequent trial block. According to the fixed cognitive results and
computational parameters, the subsequent trial block can be programmed to test the
cognitive dimensions of the subject according to resulting combinations.
The classifier component 230 can execute a plurality of algorithms and artificial
intelligence approaches for synthesizing acquired data. For example, the system can
implement a multi-layered convolutional neural network (CNN) classifier to emphasize the
multi-dimensionality of the dynamic cognitive task-computational model coupling approach
and acquired data. Then, according to the cognitive results and computational parameters
232a, 232b and 232c extracted from the subject data, the CNN classifier can assess
similarities between results of the subject and pre-defmed cognitive/computational patterns
that signify respective domains of mental/psychiatric disorders. Subsequently, the system
can utilize Random Forest to assign final probabilities.
The present disclosure can be applied to Parkinson’s disease and other neurological
disorders. It can also be used to diagnose comorbid psychiatric manifestations that affect
patients with Parkinson’s disease, such as MDD, known as comorbid MDD. Parkinson’s
disease is diagnosed by the system by varying the amount of positive and / or negative
feedback associated with stimuli during feedback-based probabilistic classification
cognitive task (FPCT); utilizing reversal trials to potentially implicate the involvement of
frontal regions in the disorder; and adding more stimuli while escalating the level of
complexity of the FPCT. The system and method of the present disclosure allows a subject
play a computer game on a phone/tablet/PC to receive a score for a potential diagnosis with
a neurological disorder. This system and method provides an efficient and convenient
diagnosis neurological disorders and comorbid mental disorders. This can help the patients
and their treating physicians address neurological and mental complaints.
FIG. 12 is a schematic flow illustration of the system and method of the present
disclosure for use in connection with Parkinson’s disease. As can be seen, the flow of FIG.
12 is similar to the that shown in FIG. 1 and like portions function in a like manner. The
flow diagram 200 shows a cognitive module 201 and a computational module 202. The
cognitive module 201 shows feedback-based probabilistic classifications (FPCT) 204
including accuracy 210 with positive feedback and negative feedback, accuracy processing
bits 212 and response time 214 with positive feedback and negative feedback. The cognitive
module 201 is in the form of a cognitive computer task. The computational module 202
includes a reinforcement learning module (RLM) 208 that calculates positive learning rates,
negative learning rates, perseveration, exploration / exploitation, valuation of positive
feedback and valuation of negative feedback. The drift diffusion module (DDM) 208
calculates drift rate, threshold separation, non-decision time, exploration / exploitation,
starting point and difference in decision time. The computational module 202 scales up the
data from the cognitive module 201 to generate more dimensions or features.
The classification algorithm 216 distinguishes between subjects with Parkinson’s
disease and healthy subjects based on cognitive predictors, including positive feedback
accuracy, negative feedback accuracy and response time to negative feedback, and based on
computational predictors, including learning noise, perseveration and positive feedback drift
rate. The classification algorithm also distinguishes between subjects with Parkinson’s
disease that have and do not have comorbid mental disorder based on cognitive predictors
including response time to negative feedback, and based on computational predictors,
including perseveration and positive feedback drift rate. An algorithm training component
220 is used to process and store data acquired over time and includes attributes 222 for
FPCT, RLM and DDM, dimension modulation 224 such as random tree embedding to
determine the separation line of those having Parkinson’s disease and those that do not, and
cross validation 226 where the process is repeated to increase certainty.
Other components 230 can include, for FPCT, multiple feedback values wherein the
reward / punishment values can be modified to accumulate more data for quicker and more
efficient diagnosis, multitude of stimuli wherein the computer task can be changed based on
the performance of the subject, conflict trials wherein the computer task can be optimized
for a subject, and reversal trials which can assess control issues and control of inhibitions.
Other components 230 can include RLM stimulus and feedback and DDM stimulus and
feedback. Other components can also include classification algorithms, including logistic
regression, support vector machine (SVM) which looks for plane of separation of subjects
and random forest which includes multiple decision trees.
When a subject performs the computer-based task in the cognitive module 201, five
cognitive attributes are generated, including: positive feedback accuracy, negative feedback
accuracy, feedback bias accuracy, positive feedback response time, and negative feedback
response time. These cognitive attributes are analyzed by RLM and DDM computational
models in the computational module 202 to produce 12 computational attributes. In
particular, RLM models 208 produce the following attributes: positive learning rate,
negative learning rate, perseveration, noise, and valuation of feedback. DDM models 206
produce the following attributes: drift rate, threshold separation, non-decision time,
difference in decision time, response speed difference, and starting point. The cognitive and
computational results from the training dataset are then used to train a classification
algorithm, such as logistic regression, support-vector machines, decision trees, or random
forest. Training confirms the attributes that will contribute to the most efficient classification
process. Cross-validation approaches are then used to confirm that the trained model can
sufficiently classify all of the assigned categories and can be generalized to new data with
similar properties. The trained algorithm is then used as the classification algorithm on new
data from new subjects.
Using data collected from a short (~10 minutes) FPCT that allows for the dissociation
of learning from positive versus negative feedback alongside mathematical models to extract
additional measures, PD can be diagnosed and an assessment can be made about whether
patients have comorbid clinical depression (PD-MDD). The collected cognitive data
(accuracy of choices and response time) are processed using two computational models: (1)
A Q-leaming RLM to assess parameters related to learning accuracy, and (2) A DDM to
assess parameters related to response time distributions. Cognitive data from the FPCT and
parameters from the two computational models are then fed into a multinomial logistic
regression model that can differentiate PD patients from healthy subjects in virtually all of
the cases. Further, these results can differentiate PD patients with PDD in virtually all of the
cases. If there is a determination that the subject has PD and/or PD-MDD, the subject can
be further evaluated and/or provided with medical treatment.
The parameters that differentiate healthy and PD subjects include:
COGNITIVELY (1) Learning accuracy from positive feedback, (2) Learning
accuracy from negative feedback, and (3) Response time to negative feedback;
COMPUTATIONALLY: (1) Learning noise, (2) Perseveration, (3) Positive
feedback drift-rate, and (4) Non-decision time parameters.
The parameters that differentiate PD patients with PDD include:
COGNITIVELY: (1) Response time to negative feedback;
COMPUTATIONALLY: (1) Learning noise, (2) Positive feedback drift-rate
parameters.
FIG. 13 is a drawing showing a classification graph for tests conducted in connection
with the system of the present disclosure to differentiate PD from PD-MDD and FIG. 14 is
a drawing showing a classification graph for tests conducted in connection with the system
of the present disclosure to differentiate PD from a healthy subject. As can be seen in FIG.
13, a forward binomial logistic regression classification graph shows a predicted probability
of membership for PD-MDD where the cutoff value can be .50 and each symbol represents
two cases. In FIG. 13, M denotes PD-MDD and P denotes PD. As can be seen in FIG. 14,
a forward binomial logistic regression classification graph shows a predicted probability of
membership for PD where the cutoff value can be .50 and each symbol represents two cases.
In FIG. 14, P denotes PD and H denotes a healthy subject.
Having thus described the system and method in detail, it is to be understood that the
foregoing description is not intended to limit the spirit or scope thereof. It will be understood
that the embodiments of the present disclosure described herein are merely exemplary and
that a person skilled in the art may make any variations and modification without departing
from the spirit and scope of the disclosure. All such variations and modifications, including
those discussed above, are intended to be included within the scope of the disclosure.
CLAIMS
1. A system for evaluating an individual comprising:
a smart device for displaying at least one image associated with a cognitive task and
receiving input data from an individual performing the cognitive task;
a remote device including a memory and a processor, the remote device receiving
data from the smart device associated with the cognitive task performed by the individual;
the remote device (i) processing the received data by computational analysis to
determine learning parameters associated with a performance of the individual, and (ii)
evaluating, based on the determined learning parameters and a classification algorithm, the
individual to determine whether the individual has a disorder.
2 . The system of Claim 1, wherein if the individual is determined to have a disorder, the
system refers the individual for further evaluation.
3 . The system of Claim 1, wherein if the individual is determined to have a disorder, the
individual is provided with medical treatment.
4 . The system of Claim 1, wherein the computational analysis includes artificial intelligence
trial-by-trial analysis.
5 . The system of Claim 1, wherein the smart device provides the individual with feedback
in response to the received input data through the cognitive task, the feedback being at least
one of positive feedback or negative feedback, reversal of feedback, outcome devaluation,
and correct feedback or incorrect feedback.
6 . The system of Claim 1, wherein the cognitive task dynamically changes based on prior
responses of the individual.
7 . The system of Claim 1, wherein the data associated with the cognitive task is analyzed
by utilizing trial-by-trial computational models and artificial intelligence approaches to
assess parameters for reinforcement learning, gain learning, loss learning, stimulus-by-
stimulus response, and drift diffusion.
8 . The system of Claim 1, wherein the classification algorithm at least one of a positive
feedback accuracy, a response time to positive feedback, a negative feedback accuracy, and
a response time to negative feedback as a cognitive predictor in evaluating the individual.
9 . The system of Claim 1, wherein the system utilizes at least one of a positive learning rate,
a negative learning rate, a separation threshold, a difference in the speed of response for the
execution of responses, and a drift rate for negative feedback as a computational or artificial
intelligence predictor in evaluating the individual.
10. A method for evaluating an individual:
displaying at least one image associated with a cognitive task on a smart device;
receiving input data from the individual for performing the cognitive task;
receiving data from the smart device associated with the cognitive task performed by
the individual;
processing the received data by computational analysis; and
evaluating, based on the processed data and a classification algorithm, the individual
to determine whether the individual has a disorder.
11. The method of Claim 10, further comprising determining, by trial-by-trial computational
and artificial intelligence analysis, learning parameters according to a performance of the
individual.
12. A system for evaluating an individual comprising:
a smart device having a display, the smart device displaying at least one image
associated with a cognitive task and receiving input data from an individual for performing
the cognitive task; and
a server including a memory and a processor, the server receiving data from the smart
device associated with the cognitive task performed by the individual;
the server evaluating, based on the received data and a classification algorithm or an
artificial intelligence approach, whether the individual has a disorder.
13. The system of Claim 12, wherein if the individual is determined to have a disorder, the
system refers the individual for further evaluation.
14. The system of Claim 12, wherein if the individual is determined to have a disorder, the
individual is provided with medical treatment.
15. The system of Claim 12, wherein the smart device (i) processes the received data by
computational analysis and artificial intelligence trial-by-trial analysis, to determine learning
parameters according to a performance of the individual, and (ii) determines, based on the
determined learning parameters and the classification algorithm whether the participant has
the disorder.
16. The system of Claim 12, wherein the smart device provides the individual with feedback
in response to the received input data through the cognitive task, the feedback being at least
one of positive feedback or negative feedback, reversal of feedback, outcome devaluation,
and correct feedback or incorrect feedback.
17. The system of Claim 12, wherein the cognitive task dynamically changes based on prior
responses of the individual.
18 . The system of Claim 12, wherein the data associated with the cognitive task is analyzed
by utilizing trial-by-trial computational models and artificial intelligence approaches to
assess parameters for reinforcement learning, gain learning, loss learning, stimulus-by-
stimulus response, and drift diffusion.
19. The system of Claim 12, wherein the classification algorithm utilizes at least one of a
positive feedback accuracy, a response time to positive feedback, a negative feedback
accuracy, and a response time to negative feedback as a cognitive predictor in evaluating the
individual.
20. The system of Claim 12, wherein the system utilizes at least one of a positive learning
rate, a negative learning rate, a separation threshold, a difference in the speed of response
for the execution of responses, and a drift rate for negative feedback as a computational or
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